STOCK TITAN

electroCore to Present at H.C. Wainwright BIOCONNECT Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

electroCore, a commercial-stage bioelectronic medicine company (NASDAQ: ECOR), announced its management team will present at the H.C. Wainwright BIOCONNECT Virtual Conference from January 10-13, 2022. The presentation is scheduled for January 10, 2022, at 7:00 am ET. Investors can register for the conference HERE.

A webcast replay will be available post-conference on the investor section of the company's website.

Positive
  • None.
Negative
  • None.

ROCKAWAY, NJ, Jan. 04, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a presentation at the H.C. Wainwright BIOCONNECT Virtual Conference. The conference is taking place virtually from January 10 - 13, 2022. Details for access to the presentation are as follows: 

H.C. Wainwright BIOCONNECT Virtual Conference:
Date: January 10, 2022
Time: 7:00 am ET
Investors can register for the conference HERE.

Following the conference, a webcast replay of the presentation will be available on the Investor section of the company’s website, electroCore.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.

For more information, visit www.electrocore.com.


FAQ

What is the date and time of the electroCore presentation at the H.C. Wainwright BIOCONNECT Virtual Conference?

The electroCore presentation is scheduled for January 10, 2022, at 7:00 am ET.

How can investors register for the H.C. Wainwright BIOCONNECT Virtual Conference featuring electroCore?

Investors can register for the conference HERE.

Where can I find the webcast of the electroCore presentation after the H.C. Wainwright conference?

The webcast replay of the electroCore presentation will be available on the investor section of the company's website.

What is the focus of electroCore's bioelectronic medicine platform?

electroCore’s platform focuses on treating multiple conditions in neurology, including cluster headaches and migraines.

Which conditions are currently treated by electroCore's therapies?

electroCore currently treats cluster headache and migraine, acute migraine, episodic cluster headache, and related conditions.

electroCore, Inc.

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Stock Data

76.33M
6.45M
25.44%
16.06%
0.41%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ROCKAWAY